Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 1631 entries
View as:

A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04993989 Org: User:
Start: 11/16/17 End: 04/18/18 Due: 04/18/19

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT03470103 Org: User:
Start: 03/28/18 End: 01/15/21 Due: 01/15/22

Hepatic Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT00829231 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01971450 Org: User:
Start: 11/21/13 End: 04/18/18 Due: 04/18/19

Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04252300 Org: User:
Start: 03/02/20 End: 12/07/20 Due: 12/07/21

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

Phase: N/A Priority: Normal
NCT ID: NCT04614246 Org: User:
Start: 01/29/21 End: 05/03/22 Due: 05/03/23

A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

Phase: N/A Priority: Normal
NCT ID: NCT04813926 Org: User:
Start: 07/16/21 End: 02/03/25 Due: 02/03/26

An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00492986 Org: User:
Start: 10/31/05 End: 11/30/08 Due: 11/30/09

Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil

Phase: N/A Priority: Normal
NCT ID: NCT00661297 Org: User:
Start: 06/30/03 End: 01/31/04 Due: 01/31/05

Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01168817 Org: User:
Start: 08/31/10 End: 05/31/11 Due: 05/31/12

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT00586105 Org: User:
Start: 12/31/05 End: 05/31/08 Due: 05/31/09

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Phase: N/A Priority: Normal
NCT ID: NCT02626455 Org: User:
Start: 01/06/16 End: 11/10/23 Due: 11/10/24

Study for Collection of Aflibercept Data in Routine Practice

Phase: N/A Priority: Normal
NCT ID: NCT02811692 Org: User:
Start: 09/30/16 End: 11/27/17 Due: 11/27/18

An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks

Phase: N/A Priority: Normal
NCT ID: NCT03556787 Org: User:
Start: 06/04/18 End: 11/08/18 Due: 11/08/19

Study to Collect Information on How Well the Study Drug Naproxen Sodium Tablets Works Compared to Hydrocodone/Acetaminophen Tablets in Order to Relieve Pain in Participants Experiencing Moderate to Severe Pain After Having Their Wisdom Teeth Removed

Phase: N/A Priority: Normal
NCT ID: NCT04307940 Org: User:
Start: 03/12/20 End: 10/05/20 Due: 10/05/21

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Phase: N/A Priority: Normal
NCT ID: NCT05915728 Org: User:
Start: 07/24/23 End: 06/01/24 Due: 06/01/25

Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT01359787 Org: User:
Start: 05/31/11 End: 09/30/11 Due: 09/30/12

Safety and Effectiveness of Regorafenib

Phase: N/A Priority: Normal
NCT ID: NCT02042144 Org: User:
Start: 04/08/14 End: 11/10/17 Due: 11/10/18

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03724747 Org: User:
Start: 12/18/18 End: 10/31/24 Due: 10/31/25

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT03194646 Org: User:
Start: 06/30/17 End: 07/11/24 Due: 07/11/25

Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01392521 Org: User:
Start: 07/31/11 End: 04/30/14 Due: 04/30/15

A Study to Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06125366 Org: User:
Start: 04/17/19 End: 07/11/19 Due: 07/11/20

18432-Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02779829 Org: User:
Start: 07/29/15 End: 09/01/15 Due: 09/01/16

Evaluate Analgesic Efficacy of Fast Release Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01122602 Org: User:
Start: 04/29/10 End: 08/06/10 Due: 08/06/11

A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05473715 Org: User:
Start: 04/25/23 End: 07/11/23 Due: 07/11/24